Belgium· BE-AMP-SAM301725-00
Mircera 150 µg/0.3 ml
A methoxy polyethylene glycol-epoetin beta product containing epoetin-beta-methoxypolyethyleneglycol, registered in Belgium by Roche Registration. The same ATC class is registered in 12 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Methoxy polyethylene glycol-epoetin beta is registered in 12 of 19 countries.
Countries holding a registration under ATC B03XA03 (methoxy polyethylene glycol-epoetin beta), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Methoxy polyethylene glycol-epoetin beta · ATC B03XA03
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of methoxy polyethylene glycol-epoetin beta costs, country by country.
Normalised to the WHO defined daily dose (4 mcg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Methoxy polyethylene glycol-epoetin beta · price per daily dose (4 mcg)
USD · FX 28 Sept 2026
- CH Switzerland$10.18
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Epoetin-Beta-Methoxypolyethyleneglycol
- Manufacturer
- Roche Registration
- Country
- Belgium (BE)
- ATC code
- B03XA03
- ATC class
- Methoxy polyethylene glycol-epoetin beta
- Defined daily dose
- 4 mcg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb0788844
- be_apb2428241
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B03XA03
Methoxy polyethylene glycol-epoetin beta, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f10da499-7d4f-4fb6-977a-a19396505761 GET /v1/drugs/f10da499-7d4f-4fb6-977a-a19396505761?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Mircera 150 µg/0.3 ml",
"name_fr": "Mircera 150 µg/0.3 ml",
"name_nl": "Mircera 150 µg/0.3 ml",
"amp_code": "SAM301725-00",
"strengths": [
"500.0000"
],
"pack_count": 1,
"substances": [
"Epoetin-Beta-Methoxypolyethyleneglycol"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Methoxy Polyethylene Glycol-Epoetin Beta",
"authorisation_numbers": [
"EU/1/07/400/011"
]
}See everything about methoxy polyethylene glycol-epoetin beta.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.